Exane Derivatives’s Tradr 2X Long Innovation ETFShort Innovation Daily ETF SARK Stock Holding History

Exane Derivatives’s Portfolio SARK Stock Details SARK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$322	Buy	+2	New	+$363	﹤0.01%	627

Other funds holding SARK

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CAM

Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

Exane Derivatives's SARK Position: Q2 2022 in Review

Exane Derivatives opened a new position in Tradr 2X Long Innovation ETFShort Innovation Daily ETF (SARK) in Q2 2022: 2 shares worth $322. The stake represents ﹤0.01% of the portfolio and ranks #627 among its holdings.

50 funds tracked by Wall St. Rank hold SARK as of Q2 2022.

Exane Derivatives held 2 shares of Tradr 2X Long Innovation ETFShort Innovation Daily ETF worth $322 as of Q2 2022.
Tradr 2X Long Innovation ETFShort Innovation Daily ETF was a new Exane Derivatives position in Q2 2022.
Tradr 2X Long Innovation ETFShort Innovation Daily ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #627 holding.
50 funds tracked by Wall St. Rank held Tradr 2X Long Innovation ETFShort Innovation Daily ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.